annual EBITDA:
-$351.67M+$75.76M(+17.72%)Summary
- As of today (June 17, 2025), IOVA annual EBITDA is -$351.67 million, with the most recent change of +$75.76 million (+17.72%) on December 31, 2024.
- During the last 3 years, IOVA annual EBITDA has fallen by -$22.95 million (-6.98%).
- IOVA annual EBITDA is now -2442066.67% below its all-time high of -$14.40 thousand, reached on December 31, 2009.
Performance
IOVA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$110.16M-$35.27M(-47.09%)Summary
- As of today (June 17, 2025), IOVA quarterly EBITDA is -$110.16 million, with the most recent change of -$35.27 million (-47.09%) on March 31, 2025.
- Over the past year, IOVA quarterly EBITDA has dropped by -$2.34 million (-2.17%).
- IOVA quarterly EBITDA is now -2275.58% below its all-time high of $5.06 million, reached on December 31, 2012.
Performance
IOVA quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$354.01M-$2.34M(-0.67%)Summary
- As of today (June 17, 2025), IOVA TTM EBITDA is -$354.01 million, with the most recent change of -$2.34 million (-0.67%) on March 31, 2025.
- Over the past year, IOVA TTM EBITDA has increased by +$76.07 million (+17.69%).
- IOVA TTM EBITDA is now -8738.91% below its all-time high of $4.10 million, reached on March 31, 2013.
Performance
IOVA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
IOVA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +17.7% | -2.2% | +17.7% |
| 3 y3 years | -7.0% | -27.0% | -3.3% |
| 5 y5 years | -76.9% | -56.1% | -54.2% |
IOVA EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -7.0% | +17.7% | -47.1% | +1.2% | -3.3% | +17.7% |
| 5 y | 5-year | -76.9% | +17.7% | -87.8% | +1.2% | -54.2% | +17.7% |
| alltime | all time | <-9999.0% | +17.7% | -2275.6% | +1.2% | -8738.9% | +17.7% |
IOVA EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$110.16M(+47.1%) | -$354.01M(+0.7%) |
| Dec 2024 | -$351.67M(-17.7%) | -$74.89M(-3.9%) | -$351.67M(-9.4%) |
| Sep 2024 | - | -$77.92M(-14.4%) | -$388.33M(-7.3%) |
| Jun 2024 | - | -$91.05M(-15.5%) | -$418.89M(-2.6%) |
| Mar 2024 | - | -$107.81M(-3.3%) | -$430.09M(+0.6%) |
| Dec 2023 | -$427.43M(+13.2%) | -$111.54M(+2.8%) | -$427.43M(+2.4%) |
| Sep 2023 | - | -$108.49M(+6.1%) | -$417.22M(+3.3%) |
| Jun 2023 | - | -$102.25M(-2.8%) | -$403.93M(+2.0%) |
| Mar 2023 | - | -$105.16M(+3.8%) | -$396.17M(+4.9%) |
| Dec 2022 | -$377.74M(+14.9%) | -$101.33M(+6.4%) | -$377.74M(+1.7%) |
| Sep 2022 | - | -$95.19M(+0.7%) | -$371.42M(+3.6%) |
| Jun 2022 | - | -$94.49M(+8.9%) | -$358.50M(+4.6%) |
| Mar 2022 | - | -$86.73M(-8.7%) | -$342.66M(+4.2%) |
| Dec 2021 | -$328.72M(+29.8%) | -$95.00M(+15.5%) | -$328.72M(+11.7%) |
| Sep 2021 | - | -$82.28M(+4.6%) | -$294.36M(+8.7%) |
| Jun 2021 | - | -$78.65M(+8.0%) | -$270.75M(+6.0%) |
| Mar 2021 | - | -$72.80M(+20.0%) | -$255.46M(+0.9%) |
| Dec 2020 | -$253.22M(+27.4%) | -$60.64M(+3.4%) | -$253.22M(+1.1%) |
| Sep 2020 | - | -$58.66M(-7.4%) | -$250.45M(+3.0%) |
| Jun 2020 | - | -$63.37M(-10.2%) | -$243.08M(+5.9%) |
| Mar 2020 | - | -$70.56M(+21.9%) | -$229.59M(+15.5%) |
| Dec 2019 | -$198.75M(+56.1%) | -$57.86M(+12.8%) | -$198.75M(+13.2%) |
| Sep 2019 | - | -$51.30M(+2.8%) | -$175.58M(+10.4%) |
| Jun 2019 | - | -$49.88M(+25.6%) | -$159.09M(+13.3%) |
| Mar 2019 | - | -$39.72M(+14.5%) | -$140.37M(+10.3%) |
| Dec 2018 | -$127.30M(+38.5%) | -$34.69M(-0.3%) | -$127.30M(+7.5%) |
| Sep 2018 | - | -$34.81M(+11.7%) | -$118.44M(+12.0%) |
| Jun 2018 | - | -$31.15M(+16.9%) | -$105.73M(+8.0%) |
| Mar 2018 | - | -$26.65M(+3.2%) | -$97.91M(+6.5%) |
| Dec 2017 | -$91.92M(+74.6%) | -$25.83M(+16.9%) | -$91.92M(+12.5%) |
| Sep 2017 | - | -$22.10M(-5.3%) | -$81.73M(+4.2%) |
| Jun 2017 | - | -$23.34M(+13.0%) | -$78.46M(+17.8%) |
| Mar 2017 | - | -$20.66M(+32.2%) | -$66.58M(+26.4%) |
| Dec 2016 | -$52.66M | -$15.63M(-17.0%) | -$52.66M(+16.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2016 | - | -$18.83M(+64.4%) | -$45.20M(+33.9%) |
| Jun 2016 | - | -$11.46M(+69.9%) | -$33.74M(+18.4%) |
| Mar 2016 | - | -$6.74M(-17.5%) | -$28.49M(+6.1%) |
| Dec 2015 | -$26.86M(+124.7%) | -$8.17M(+10.8%) | -$26.86M(+14.3%) |
| Sep 2015 | - | -$7.38M(+19.0%) | -$23.49M(+24.2%) |
| Jun 2015 | - | -$6.20M(+21.3%) | -$18.91M(+27.6%) |
| Mar 2015 | - | -$5.11M(+6.5%) | -$14.82M(+24.0%) |
| Dec 2014 | -$11.95M(-47.2%) | -$4.80M(+71.7%) | -$11.95M(-35.9%) |
| Sep 2014 | - | -$2.80M(+32.7%) | -$18.65M(-26.2%) |
| Jun 2014 | - | -$2.11M(-6.0%) | -$25.25M(-4.6%) |
| Mar 2014 | - | -$2.24M(-80.5%) | -$26.47M(+6.2%) |
| Dec 2013 | -$22.63M(+2467.7%) | -$11.50M(+22.2%) | -$24.93M(+197.8%) |
| Sep 2013 | - | -$9.41M(+183.0%) | -$8.37M(-1805.2%) |
| Jun 2013 | - | -$3.32M(+372.8%) | $490.90K(-88.0%) |
| Mar 2013 | - | -$703.00K(-113.9%) | $4.10M(-564.7%) |
| Dec 2012 | -$881.50K(-95.7%) | $5.06M(-1028.4%) | -$881.80K(-90.4%) |
| Sep 2012 | - | -$545.40K(-292.7%) | -$9.18M(-36.3%) |
| Jun 2012 | - | $283.00K(-105.0%) | -$14.40M(-42.9%) |
| Mar 2012 | - | -$5.68M(+75.8%) | -$25.22M(+25.0%) |
| Dec 2011 | -$20.54M(+2614.0%) | -$3.23M(-44.0%) | -$20.18M(+16.1%) |
| Sep 2011 | - | -$5.77M(-45.3%) | -$17.39M(+47.5%) |
| Jun 2011 | - | -$10.54M(+1547.0%) | -$11.79M(+786.7%) |
| Mar 2011 | - | -$640.10K(+45.5%) | -$1.33M(+75.6%) |
| Dec 2010 | -$756.80K(+5155.6%) | -$440.00K(+167.2%) | -$757.00K(+137.3%) |
| Sep 2010 | - | -$164.70K(+94.7%) | -$319.00K(+102.7%) |
| Jun 2010 | - | -$84.60K(+25.0%) | -$157.40K(+107.7%) |
| Mar 2010 | - | -$67.70K(+3285.0%) | -$75.80K(+426.4%) |
| Dec 2009 | -$14.40K(-74.2%) | -$2000.00(-35.5%) | -$14.40K(-45.5%) |
| Sep 2009 | - | -$3100.00(+3.3%) | -$26.40K(+3.9%) |
| Jun 2009 | - | -$3000.00(-52.4%) | -$25.40K(-31.5%) |
| Mar 2009 | - | -$6300.00(-55.0%) | -$37.10K(-33.5%) |
| Dec 2008 | -$55.80K | -$14.00K(+566.7%) | -$55.80K(+33.5%) |
| Sep 2008 | - | -$2100.00(-85.7%) | -$41.80K(+5.3%) |
| Jun 2008 | - | -$14.70K(-41.2%) | -$39.70K(+58.8%) |
| Mar 2008 | - | -$25.00K | -$25.00K |
FAQ
- What is Iovance Biotherapeutics annual EBITDA?
- What is the all time high annual EBITDA for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics annual EBITDA year-on-year change?
- What is Iovance Biotherapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics quarterly EBITDA year-on-year change?
- What is Iovance Biotherapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics TTM EBITDA year-on-year change?
What is Iovance Biotherapeutics annual EBITDA?
The current annual EBITDA of IOVA is -$351.67M
What is the all time high annual EBITDA for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high annual EBITDA is -$14.40K
What is Iovance Biotherapeutics annual EBITDA year-on-year change?
Over the past year, IOVA annual EBITDA has changed by +$75.76M (+17.72%)
What is Iovance Biotherapeutics quarterly EBITDA?
The current quarterly EBITDA of IOVA is -$110.16M
What is the all time high quarterly EBITDA for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high quarterly EBITDA is $5.06M
What is Iovance Biotherapeutics quarterly EBITDA year-on-year change?
Over the past year, IOVA quarterly EBITDA has changed by -$2.34M (-2.17%)
What is Iovance Biotherapeutics TTM EBITDA?
The current TTM EBITDA of IOVA is -$354.01M
What is the all time high TTM EBITDA for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high TTM EBITDA is $4.10M
What is Iovance Biotherapeutics TTM EBITDA year-on-year change?
Over the past year, IOVA TTM EBITDA has changed by +$76.07M (+17.69%)